#HedgePapers No. 35 – Billionaire John Paulson – The Epi-Pen Profiteer

30 Aug 2016

Right now, price gouging for the EpiPen is putting a lifesaving medication out of reach for thousands of American families, while at the same time helping a manipulative hedge fund billionaire get even richer. Families shouldn’t have to choose between lifesaving drugs and putting food on the table – it’s unfair, and it’s morally wrong.... Read More

#HEDGEPAPERS NO. 22 – Hedge Funds Attack American Health Care

30 Sep 2015

Billionaire Profiteers & Big Pharma A new analysis shows rampant speculation by hedge fund and private equity in the branded drugs that are rising fastest in price It’s not just one highly unethical man: dozens of high-flying financial speculators at hedge funds and private equity firms are driving up the price of pharmaceuticals across the country.... Read More

#HedgePapers No. 13 – Hepatitis C and Hedge Fund Profiteers

4 May 2015

HEPATITIS C AND HEDGE FUND PROFITEERS Meet The Hedge Fund Managers Cashing In On Predatory Drug Pricing Schemes from Gilead Sciences For millions of Americans infected with Hepatitis C, the inflated prices of new Hepatitis C drugs from Gilead Sciences translate into limited access and prolonged illness. The pharmaceutical giant is charging as much as $1,125 per pill and $94,500 for a course of its lifesaving treatments, forcing health care systems to limit access, robbing patients of a decent quality of life, and forcing many into serious health problems and complications.... Read More